Related Experiment Video
Updated: Sep 8, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53-Mediated Indirect Regulation on Cellular Metabolism: From the Mechanism of Pathogenesis to the Development of
Chen-Yun Wang1,2, Chi-Hong Chao1,2,3
1Institute of Molecular Medicine and Bioengineering, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
Abstract:
The transcription factor p53 is the most well-characterized tumor suppressor involved in multiple cellular processes, which has expanded to the regulation of metabolism in recent decades. Accumulating evidence reinforces the link between the disturbance of p53-relevant metabolic activities and tumor development. However, a full-fledged understanding of the metabolic roles of p53 and the underlying detailed molecular mechanisms in human normal and cancer cells remain elusive, and persistent endeavor is required to foster the entry of drugs targeting p53 into clinical use. This mini-review summarizes the indirect regulation of cellular metabolism by wild-type p53 as well as mutant p53, in which mechanisms are categorized into three major groups: through modulating downstream transcriptional targets, protein-protein interaction with other transcription factors, and affecting signaling pathways. Indirect mechanisms expand the p53 regulatory networks of cellular metabolism, making p53 a master regulator of metabolism and a key metabolic sensor. Moreover, we provide a brief overview of recent achievements and potential developments in the therapeutic strategies targeting mutant p53, emphasizing synthetic lethal methods targeting mutant p53 with metabolism. Then, we delineate synthetic lethality targeting mutant p53 with its indirect regulation on metabolism, which expands the synthetic lethal networks of mutant p53 and broadens the horizon of developing novel therapeutic strategies for p53 mutated cancers, providing more opportunities for cancer patients with mutant p53. Finally, the limitations and current research gaps in studies of metabolic networks controlled by p53 and challenges of research on p53-mediated indirect regulation on metabolism are further discussed.
Insights
The tumor suppressor p53 indirectly regulates cellular metabolism through various mechanisms, offering new therapeutic targets for p53-mutated cancers. Understanding these metabolic roles is key for developing novel cancer treatments.
Area of Science:
- Molecular Biology
- Cancer Research
- Metabolic Regulation
Background:
- The tumor suppressor p53 is crucial in cellular processes and metabolism.
- Disruptions in p53-related metabolism are linked to cancer development.
- Detailed mechanisms of p53's metabolic roles in human cells are not fully understood.
Purpose of the Study:
- To review the indirect regulation of cellular metabolism by wild-type and mutant p53.
- To explore therapeutic strategies targeting mutant p53, focusing on synthetic lethality.
- To identify research gaps and challenges in p53-mediated metabolic regulation.
Main Methods:
- Categorization of p53's indirect metabolic regulation into three mechanisms: downstream targets, protein-protein interactions, and signaling pathways.
- Overview of recent therapeutic advancements targeting mutant p53.
- Discussion of synthetic lethality approaches.
Main Results:
- p53 acts as a master regulator and metabolic sensor through indirect mechanisms.
- Indirect regulation expands p53's role in cellular metabolism.
- Synthetic lethality targeting mutant p53 with metabolism offers new therapeutic avenues.
Conclusions:
- Indirect metabolic regulation by p53 provides novel therapeutic targets for p53-mutated cancers.
- Synthetic lethality broadens treatment options for patients with mutant p53.
- Further research is needed to address current limitations and challenges.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway

